Home
|
About IJNM
|
Search
|
Current Issue
|
Past Issues
|
Instructions
|
Ahead of Print
|
Online submission
|
Reader Login
Editorial Board
|
Subscribe
|
Advertise
|
Contact
Users Online: 611
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2022| July-September | Volume 37 | Issue 3
Online since
November 2, 2022
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
ORIGINAL ARTICLES
Radiomic analysis of positron-emission tomography and computed tomography images to differentiate between multiple myeloma and skeletal metastases
Pallavi Mannam, Arunan Murali, Periakaruppan Gokulakrishnan, Easwaramoorthy Venkatachalapathy, Pulivadula Mohanarangam Venkata Sai
July-September 2022, 37(3):217-226
DOI
:10.4103/ijnm.ijnm_111_21
Context:
Multiple myeloma and extensive lytic skeletal metastases may appear similar on positron-emission tomography and computed tomography (PET-CT) in the absence of an obvious primary site or occult malignancy. Radiomic analysis extracts a large number of quantitative features from medical images with the potential to uncover disease characteristics below the human visual threshold.
Aim:
This study aimed to evaluate the diagnostic capability of PET and CT radiomic features to differentiate skeletal metastases from multiple myeloma.
Settings and Design:
Forty patients (20 histopathologically proven cases of multiple myeloma and 20 cases of a variety of bone metastases) underwent staging 18F-fluorodeoxyglucose PET-CT at our institute.
Methodology:
A total of 138 PET and 138 CT radiomic features were extracted by manual semi-automatic segmentation and standardized. The original dataset was subject separately to receiver operating curve analysis and correlation matrix filtering. The former showed 16 CT and 19 PET parameters to be significantly related to the outcome at 5%, whereas the latter resulted in 16 CT and 14 PET features. Feature selection was done with 7 evaluators with stratified 10-fold cross-validation. The selected features of each evaluator were subject to 14 machine-learning algorithms. In view of small sample size, two approaches for model performance were adopted: The first using 10-fold stratified cross-validation and the second using independent random training and test samples (26:14). In both approaches, the highest area under the curve (AUC) values were selected for 5 CT and 5 PET features. These 10 features were combined and the same process was repeated.
Statistical Analysis Used:
The quality of the performance of the models was assessed by MSE, RMSE, kappa statistic, AUC, area under the precision-recall curve, F-measure, and Matthews correlation coefficient.
Results:
In the first approach, the highest AUC = 0.945 was seen with 5 CT parameters. In the second approach, the highest AUC = 0.9538 was seen with 4 CT and one PET parameter. CT neighborhood gray-level different matrix coarseness and CT gray-level run-length matrix LGRE were common parameters in both approaches. Comparison of AUC of the above models showed no significant difference (
P
= 0.9845). Feature selection by principal components analysis and feature classification by the multilayer perceptron machine-learning model using independent training and test samples yielded the overall highest AUC.
Conclusions:
Machine-learning models using CT parameters were found to differentiate bone metastases from multiple myeloma better than models using PET parameters. Combined models using PET and CECT data showed better overall performance than models using only either PET or CECT data. Machine-learning models using independent training and test sets were performed on par with those using 10-fold stratified cross-validation with the former incorporating slightly more PET features. Certain first- and second-order CT and PET texture features contributed in differentiating these two conditions. Our findings suggested that, in general, metastases were finer in CT and PET texture and myelomas were more compact.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
781
146
-
Sentinel node mapping in early breast cancer: A randomized comparison of fluorescein guided all india institute of medical sciences, anurag's technique with technetium-99 m sulfur colloid plus methylene blue
Sarada Khadka, Jayesh Suresh, Amar Prem, Piyush Ranjan Mishra, Kamal Kataria, Anita Dhar, Vuthaluru Seenu, Chandershekhar Bal, Rakesh Kumar, Sandeep Mathur, Smriti Hari, Ravindra Mohan Pandey, Anurag Srivastava
July-September 2022, 37(3):236-244
DOI
:10.4103/ijnm.ijnm_3_22
Purpose:
Evaluation of fluorescein along with blue dye as an affordable tracer for sentinel node biopsy in comparison with technetium + methylene blue. A randomized trial was conducted with the following objectives: (1) to demonstrate that the identification of sentinel lymph node by fluorescein + methylene blue is not inferior to the identification by Tc-99 m sulfur colloid + methylene blue and (2) to evaluate the cost-effectiveness of sentinel node biopsy by above two tracers.
Subjects
and Methods:
One-thirty patients above age 18 years presenting with early breast cancer T1, T2, N0 breast carcinoma were randomized to undergo sentinel node biopsy by either fluorescein + methylene blue or Tc-99 m sulfur colloid + methylene blue.
Results:
The sentinel lymph nodes were identified in 89% in Fluorescein + methylene blue group and 90.9% with Tc-99 m sulfur colloid + methylene blue group. The trial demonstrated noninferiority of fluorescein + methylene blue as compared to isotope + methylene blue with effect size = 1; 95% confidence interval- 9.54 to + 11.54. The fluorescein + methylene blue was more cost-effective than isotope guided sentinel node biopsy.
Conclusion:
Fluorescein-guided sentinel node biopsy is noninferior and more cost-effective than isotope-guided sentinel node biopsy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
659
121
-
Fluoro-2-deoxyglucose-positron emission tomography/computed tomography in the diagnosis and management of adrenocortical carcinoma: A 10-year experience from a tertiary care institute
Venkata Subramanian Krishnaraju, Rajender Kumar, Karthikeyan Subramanian, Bhagwant Rai Mittal, Harmandeep Singh, Debajyoti Chatterjee, Rama Walia
July-September 2022, 37(3):227-235
DOI
:10.4103/ijnm.ijnm_4_22
Purpose:
Adrenocortical carcinoma (ACC) is a rare primary malignancy of the adrenal gland. The present study was aimed to compare the performance of fluoro-2-deoxyglucose-positron emission tomography–computed tomography (FDG-PET-CT) compared to contrast-enhanced computed tomography (CECT) in diagnosis and management of ACC.
Materials and Methods:
A retrospective analysis of the PET-CT studies from January 2010 to October 2020 was performed. Patients with adrenal lesions suspicious of ACC and diagnosed cases of ACC who underwent PET-CT for staging, restaging, and surveillance were reanalyzed. The PET-CT parameters were compared with the clinical, biochemical, histopathological, and CECT parameters.
Results:
The study included 96 scans performed in 77 patients (36 males, aged 40.4 ± 17.9 years). Of these, 55 scans were performed to diagnose and stage suspected ACC (30 of them diagnosed as ACC), 31 for restaging, and 10 scans for surveillance of ACC. PET/CT revealed metastases from an extra-adrenal primary in 5/55 patients. FDG-PET-CT had a sensitivity and specificity of 100% and 70% to diagnose ACC. Standardized uptake value-peak more than 5.4 had a sensitivity of 90.9% and specificity of 91.7% for differentiating ACC from non-ACC lesions, while tumor-to-liver ratio peak (TLRpeak) of 3.3 was most specific. PET-CT changed the staging in 23.3% of the patients with an accuracy of 100%. PET-CT changed the management plan in 25.8% of the patients during restaging with a sensitivity and specificity of 95.6% and 100%, respectively. For surveillance, CECT was as sensitive as PET-CT; however, PET-CT was more specific (100% vs. 97.9%).
Conclusion:
FDG-PET-CT performs better than CECT in the diagnosis, staging, restaging, and surveillance of ACC.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
602
97
-
Contrast enhancement of scintigraphic image using fuzzy intensification
Anil Kumar Pandey, Sakshi Dogra, Param Dev Sharma, Jasim Jaleel, Chetan Patel, Rakesh Kumar
July-September 2022, 37(3):209-216
DOI
:10.4103/ijnm.ijnm_210_21
Introduction:
The objective of this study was to see the effect of fuzzy intensification (INT) operator on enhancement of scintigraphic image.
Materials and Methods:
Nuclear medicine physician (NMP) provided 25 scintigraphic images that required enhancement. The image pixels value was converted into fuzzy plane and was subjected to contrast INT operator with parameters of INT operator i.e., cross-over = 0.5 and number of iterations = 1 and 2. The enhanced image was again brought back into spatial domain (de-fuzzification) whose intensity value was in the range 0–255. NMP compared the enhanced image with its input image and labeled it as acceptable or unacceptable. The quality of enhanced image was also accessed objectively using four different image metrics namely: Entropy, edge content, absolute mean brightness error and saturation metrics.
Results:
Most of the enhanced images (18 out of 25 images) obtained at cross-over = 0.5 and number of iterations = 1 are acceptable and found to have overall better contrast compared to the corresponding input image. Four images (two brain positron emission tomography scan and two I-131 scan) obtained at cross-over = 0.5 and with iteration = 2 are acceptable. Three input images (one dimercaptosuccinic acid (DMSA), one I-131 and one I-131- metaiodo-benzyl-guanidine (MIBG) scan) were better than their enhanced images.
Conclusions:
The enhancement produced by fuzzy INT operator was encouraging. Majority of enhanced images were acceptable at cross-over = 0.5 and number iterations = 1.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
572
92
-
CASE REPORTS
An unusual case of glioblastoma multiforme, presenting as skeletal superscan
Komal Bishnoi, Girish Kumar Parida, Rachit Thavnani, P Sai Sradha Patro, Kanhaiyalal Agrawal
July-September 2022, 37(3):268-270
DOI
:10.4103/ijnm.ijnm_209_21
Extracranial metastases of glioblastoma multiforme (GBM) are very rare. The estimated incidence is <2%. We report a case of a 49-year-old woman, who was a known case of GBM in the left temporo-occipital lobe. She was operated and had received radiotherapy and adjuvant chemotherapy for the same. Subsequently, the patient underwent bone scan. On 99 m-Tc methylene diphosphonate (MDP) bone scan, homogenously increased tracer uptake was noted in the axial and appendicular skeletal system, suggesting metastatic skeletal superscan.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
509
83
-
ORIGINAL ARTICLES
Correlation of target volumes on magnetic resonance imaging and prostate-specific membrane antigen brain scans in the treatment planning of glioblastomas
Vutkuri Lavanya, Irukulla Monica Malik, Kavitha Nallapareddy, Madhur Srivastava, Deepthi Valiyaveettil, Syed Fayaz Ahmed
July-September 2022, 37(3):245-248
DOI
:10.4103/ijnm.ijnm_189_21
Background:
Imaging of gliomas/glioblastomas has always been challenging. Many magnetic resonance imaging (MRI) techniques are available for imaging glioblastomas. MRI cannot always differentiate tumor from nonspecific changes and postoperative changes in brain tissue. Among the new positron emission tomography–computed tomography (PET-CT) tracers, gallium-68 prostate-specific membrane antigen (Ga-68 PSMA-11 PET-CT) appears to be the most promising one. The absence of uptake by normal brain parenchyma leads to high tumor-to-background ratio leading to better visualization of the tumor.
Objective:
The aim of this study was to assess the correlation of target volumes on MRI and PSMA brain scans in the treatment planning of glioblastomas.
Materials and Methods:
Twenty-four patients in the age group of 5–75 years with histologically proven glioblastoma were included in the study following maximum safe resection. Simulation for treatment planning was done with Ga-68 PSMA PET-CT brain with IV iodine-based contrast. The pre- and postoperative MRI images were fused with PSMA simulation images. Gross tumor volumes (GTVs) contoured on T1-contrast MRI and on PSMA scans were compared.
Results:
GTV contoured on MRI and PSMA brain scans showed complete overlap in 17 patients. In seven patients, the target volumes drawn on Ga-68 PSMA brain scans were slightly smaller than the target volumes drawn on MRI brain scans. This difference in volumes could be due to postoperative changes which showed enhancement on the MRI scan.
Conclusion:
Ga-68 PSMA PET-CT shows good correlation with MRI brain in the evaluation and RT planning in glioblastomas. Tumor necrosis and postoperative changes did not show PSMA uptake. Precise target delineation on PSMA PET-CT can potentially result in smaller and more accurate GTVs, which in turn would result in less RT-induced side effects.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
460
96
-
INTERESTING IMAGES
Multimodality molecular imaging in arthropathy associated with multiple myeloma
Ludmila Santiago Almeida, Stephan Pinheiro Macedo de Souza, Fernando Vieira Pericole de Souza, Fabiano Reis, Celso Dario Ramos
July-September 2022, 37(3):290-292
DOI
:10.4103/ijnm.ijnm_205_21
We report a patient with multiple myeloma (MM) and polyarthritis of large joints. During the staging of the disease, bone marrow diffusely involved by MM was clearly demonstrated by 99mTc-2-methoxy-isobutyl-isonitrile (MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) but not by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/CT images. On the other hand, a very intense uptake of 18F-FDG was detected in periarticular tissues of multiple joints, with nonabnormal 99mTc-MIBI accumulation. Rheumatology tests were negative. A subsequent bone scintigraphy demonstrated radiolabeled bisphosphonate accumulation in periarticular tissues, suggesting amyloid arthropathy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
462
88
-
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a case of subcutaneous T-cell lymphoma presenting as breast mass and panniculitis-like features: A rare entity
Ayush Mishra, Vivek Kumar Saini, Bela Jain, Amitabh Arya, Manish Ora, Sanjay Gambhir
July-September 2022, 37(3):281-283
DOI
:10.4103/ijnm.ijnm_139_21
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an unusual subtype of cutaneous lymphoma and clinically appears as erythematous, subcutaneous infiltrates, and recurrent papulonodules. It is defined as a rare cytotoxic a/b T-cell lymphoma characterized by primary involvement of subcutaneous tissue-mimicking panniculitis and a predominant CD3+/CD4/CD8+ phenotype in (2005) the World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. On metabolic imaging, these lesions are invariably fluorodeoxyglucose (FDG) avid. SPTCL which presents as a breast mass is a rare entity. Here, we present a case of SPTCL presents as FDG avid breast mass and subcutaneous nodules.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
468
80
-
PICTORIAL ESSAY
Role of positron emission tomography/computed tomography in gastrointestinal malignancies: A brief review and pictorial eswsay
Anshul Sharma, Shubha G Ravindra, Tejesh Pratap Singh, Rakesh Kumar
July-September 2022, 37(3):249-258
DOI
:10.4103/ijnm.ijnm_208_21
Positron emission tomography/computed tomography (PET/CT) is increasingly becoming a mainstay in diagnosis and management of many malignant disorders. However, its role in the assessment of gastro-intestinal lesions is still evolving. The aim of this review was to demonstrate the areas, where PET/CT is impactful and where it has limitations. This will allow for us to reduce unnecessary investigations and develop methods to overcome the limitations.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
426
87
-
INTERESTING IMAGES
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques
Angelo Castello, Matteo Caracciolo, Luca Urso, Naima Ortolan, Alberto Nieri, Stefano Panareo, Mirco Bartolomei
July-September 2022, 37(3):279-280
DOI
:10.4103/ijnm.ijnm_126_21
A 46-year-old female with Sjögren's syndrome previously treated with corticosteroids was referred to our department for suspicious humeral head osteonecrosis. Dual-phase bone scan showed an increased radiotracer distribution in the head of the left humerus. Nevertheless, whole-body scan revealed multiple sites of heterogeneous skeletal uptake. As lymphoproliferative disorder was hypothesized, also based on laboratory examination, F-18 fluorodeoxyglucose positron-emission tomography/computed tomography was performed and showed increased uptake in several osseous structures and in the subcutaneous nodules. Finally, bone marrow biopsy confirmed the diagnosis of acute myeloid leukemia as well as skin nodule biopsy revealed infiltration by malignant cells.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
432
80
-
CASE REPORTS
Primary biliary tuberculosis masquerading cholangiocarcinoma in
18
F-fluorodeoxyglucose positron emission tomography/computed tomography
Sarin Krishna, Ajit Kumar Mishra, Mudalsha Ravina, Yashwanth Kashyap, Himanshu Bansal, Subhajit Dasgupta
July-September 2022, 37(3):265-267
DOI
:10.4103/ijnm.ijnm_204_21
Hepatobiliary involvement is a less common manifestation of abdominal tuberculosis. We present the case of a 42-year-old female who presented with fever, abdominal pain, and jaundice of 2 months duration.
18
F-fluorodeoxyglucose positron emission tomography/computed tomography done for disease evaluation suggested the likely possibility of cholangiocarcinoma but excision biopsy from periportal lymph node later confirmed a granulomatous etiology and she was successfully treated with antitubercular therapy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
442
62
-
INTERESTING IMAGES
Ga-68 chemokine receptor-4 PET/CT imaging in schminke type of nasopharyngeal carcinoma
Arivan Ramachandran, Venkata Subramanian Krishnaraju, Rajender Kumar, Jaya Shukla, Ishita Laroya
July-September 2022, 37(3):284-285
DOI
:10.4103/ijnm.ijnm_184_21
Nasopharyngeal carcinoma is a rare malignancy of the head-and-neck region. It is associated with Epstein–Barr virus infection and smoking. Its association with breast cancer is also infrequent. Chemokine receptor (CXCR)-4 imaging is a newer agent for imaging many malignancies with a good diagnostic value. We present a case of a young female diagnosed with left breast carcinoma in whom Ga-68 CXCR-4 PET/CT demonstrated tracer avid lesion in the nasopharynx. Biopsy of the nasopharyngeal lesion revealed Schminke type of lymphoepithelial cancer, indicating CXCR-4 PET/CT as a potential imaging modality for lymphoepithelial malignancy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
412
72
-
99m
Tc-ethambutol scan with SPECT/CT in knee joint tuberculosis
Simran Kalra, Nishikant Avinash Damle, Piyush Ranjan, Sunit Sikdar, Geetanjali Arora, Ankur Goyal, Deepak Gautam
July-September 2022, 37(3):295-296
DOI
:10.4103/ijnm.ijnm_16_22
Modalities for
in vivo
imaging of
Mycobacterium tuberculosis
are limited and inadequately studied. One such modality is
99m
Tc-ethambutol scintigraphy which has shown promising results for diagnosis of tuberculosis (TB). Ethambutol, one of the primary antitubercular drugs, is bacteriostatic which acts on the mycolic acid cell wall synthesis of the
M. tuberculosis
. However, literature on its utility is scarce. The few studies that exist have reported its sensitivity and specificity between 90%– 95% and 71%–85%. We present here a case demonstrating the role of
99m
Tc-ethambutol scan in knee joint TB.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
390
66
-
A curious case of suspicious lymphadenopathy in a hereditary spherocytosis patient reported as extramedullary hematopoiesis
Dikhra Khan, Anshul Sharma, Sambit Sagar, T Thayumanavan, Rakesh Kumar
July-September 2022, 37(3):293-294
DOI
:10.4103/ijnm.ijnm_10_22
We present a case of a 23-year-old male patient with complaints of fever, cough, and persistent anemia for the past 6 months and with a known history of hereditary spherocytosis. Computed tomography (CT) thorax demonstrated multiple paravertebral lesions in the bilateral thoracic cavities, suggestive of lymphadenopathy; subsequently,
18
Flurodeoxyglucose PET/CT was done with suspicion of lymphoma, which showed no significant metabolic activity in those lesions. Thus, in view of clinical and metabolic status, lesions were considered extramedullary hematopoiesis (EMH). This case highlights the importance of considering EMH, while interpreting suspicious lymphadenopathy in cases of chronic anemia and also possible scan findings in the same.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
372
74
-
CASE REPORTS
A comparative case study between gallium-67 citrate scintigraphy and gallium-68 citrate positron emission tomography-computed tomography in bone infection
Hanna Elizabeth Johnson, Junita Rachel John, Justin Benjamin, Julie Hephzibah
July-September 2022, 37(3):271-273
DOI
:10.4103/ijnm.ijnm_158_21
Bone infections are a common problem, and early diagnosis and intervention can lead to better clinical outcomes and prognoses. Here, we compare the well-known tracers Gallium-67 (Ga-67) citrate versus Ga-68 citrate in the diagnosis of infections.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
380
64
-
A Rare Case of Incidental Finding of Cervical Spinal Cord Hemangioblastoma by
68
Ga-DOTATOC Positron Emission Tomography/Computed Tomography Scan
Pietro Bellini, Francesco Dondi, Domenico Albano, Francesco Bertagna
July-September 2022, 37(3):259-260
DOI
:10.4103/ijnm.ijnm_197_21
Hemangioblastomas are rare vascular tumors of the central nervous system usually related to other pathological conditions, such as Von Hippel Lindau Syndrome (VHLS) and polycythemia. We describe a case of a 65-year-old man with a neuroendocrine tumor of the ileum presenting with cervical pain who underwent a
68
Ga-DOTATOC positron emission tomography/computed tomography (PET/CT) scan that incidentally underlines the presence of hemangioblastoma of the cervical spinal cord. The patient does not have a family history of VHLS nor does he suffer from polycythemia and he is currently waiting for genetic testing. Despite being rare, hemangioblastomas could be possible findings of central nervous system incidentaloma at
68
Ga-DOTATOC PET/CT scan, especially in patients with anamnesis with possible related condition.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
374
69
-
INTERESTING IMAGES
Functional characterization of posttraumatic heterotopic ossification of tibiofibular syndesmosis with dynamic bone scan and single-photon emission computed tomography/computed tomography
Bhavana Shyamanur, Najeeb Ahmed, Sharjeel Usmani
July-September 2022, 37(3):286-287
DOI
:10.4103/ijnm.ijnm_124_21
A 53-year-old man was investigated for ongoing right ankle pain and lateral malleolus swelling following a traumatic inversion injury 12 weeks prior. The initial ankle radiograph was normal with no evidence of fracturing. The follow-up radiograph showed bridging ossification in the distal tibiofibular syndesmosis. As the pain did not subside, posttraumatic heterotopic ossification (HO) was suspected, and triple-phase dynamic bone imaging with technetium 99m-methylene diphosphonate was performed to guide further management. The bone scan revealed intense focal tracer activity centered on the HO of the tibiofibular syndesmosis, with no evidence of occult fracturing confirming HO as a pain generator.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
366
53
-
F-18 PSMA uptake in male breast cancer during restaging evaluation of carcinoma prostate
Anand Zade, Shishir Shetty, Asawari Ambekar, Makarand Karpe
July-September 2022, 37(3):277-278
DOI
:10.4103/ijnm.ijnm_127_21
Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
350
62
-
Corticomedullary mixed tumor of the adrenal gland with apparent
18
F-fluorodeoxyglucose activity but no
68
GA-DOTATATE uptake on positron emission tomography/computed tomography
Ceren Ozge Engur, Tugce Apaydın, Tunc Ones, Hulya Iliksu Gozu, Salih Ozguven
July-September 2022, 37(3):297-298
DOI
:10.4103/ijnm.ijnm_194_21
Corticomedullary mixed tumor (CMT) is a single adrenal tumor mass composed histologically by an admixture of adrenal cortical and medullary cells. It is a rare condition, with approximately 20 cases reported to date. To our knowledge, the positron emission tomography (PET) imaging findings of this mostly benign tumor have not been reported in the literature. We present a case of CMT who was evaluated with both
18
F-fluorodeoxyglucose (
18
F-FDG) and
68
Ga-DOTATATE. The hypermetabolic tumor seen on
18
F-FDG PET/computed tomography scan showed no abnormal uptake by
68
Ga-DOTATATE.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
338
64
-
CASE REPORTS
Utility of fluorine-18-labeled fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of erdheim–chester disease with multisystemic involvement
Dinesh Kumar Gauthaman, Padma Subramanyam, Jyotsna Yesodharan, Shanmuga Sundaram Palaniswamy
July-September 2022, 37(3):261-264
DOI
:10.4103/ijnm.ijnm_206_21
Erdheim‒Chester disease (ECD) is a rare non-Langerhans' cell histiocytic proliferative disorder of unknown origin with multisystemic predilection. It commonly affects adults in the fifth–seventh decades of life, with male preponderance, and has nonspecific clinical manifestations. Presence of characteristic radiological findings and demonstration of CD68 positive xanthogranulomatous infiltrates in histology clinches the diagnosis. Nevertheless, being a nonmalignant condition, it might be fatal due to multiorgan dysfunction. Hence, timely diagnosis and initiation of treatment with corticosteroids, immunosuppressants, or tyrosine kinase inhibitors are of paramount importance. We present a case of ECD with multisystemic involvement, who was initially evaluated for the left lung mass and treated as tuberculosis, where fluorine-18-labeled fluorodeoxyglucose positron emission tomography/computed tomography aided in targeting the metabolically active site for biopsy as well as assessing the multisystemic involvement.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
326
56
-
INTERESTING IMAGES
A rare case of massive bilateral renomegaly due to primary involvement by mantle cell lymphoma on
18
F-fluorodeoxyglucose positron emission tomography/computed tomography
Ritanshu Solanki, Anwin Joseph Kavanal, Harmandeep Singh, Rajender Kumar, Gaurav Prakash
July-September 2022, 37(3):299-300
DOI
:10.4103/ijnm.ijnm_44_22
Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin's lymphoma with an annual incidence of 5%, common in men with a median age of 60–70 years. Renal involvement is seen in about 0.7% of the extranodal lymphomas. The bilateral presentation is seen in 10%–20% of cases. There have been many case reports of MCL with renal involvement; however, primary renal involvement by MCL is extremely rare. We hereby describe the
18
F-fluorodeoxyglucose positron emission tomography/computed tomographic findings in primary MCL involving the bilateral kidneys.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
310
70
-
CASE REPORTS
Fluorodeoxyglucose positron emission tomography-computerized tomography scan in LGI A1-positive limbic encephalitis and concordance with MRI in a known case of carcinoma breast
Hemant Rathore, Jaiswar Rajnath
July-September 2022, 37(3):274-276
DOI
:10.4103/ijnm.ijnm_12_21
The limbic encephalitis is an autoimmune disorder which characterized by inflammation of the brain with rapidly progressing dementia either due to paraneoplastic or nonparaneoplastic etiology which requires definitive neurological and whole-body evaluation. We describe both clinical and nuclear medicine imaging and radiological findings in a case of limbic encephalitis using positron emission tomography and magnetic resonance imaging.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
306
66
-
INTERESTING IMAGES
Brown Tumors Secondary to Tertiary Hyperparathyroidism Masquerading as Lytic or Sclerotic Skeletal Metastases on Preoperative/Postoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Case Report
Ceren Ozge Engur, Tunc Ones, Nuh Filizoglu, Selin Kesim, Salih Ozguven
July-September 2022, 37(3):288-289
DOI
:10.4103/ijnm.ijnm_195_21
Tertiary hyperparathyroidism (TH) is a rare condition that develops from secondary hyperparathyroidism in cases when the secretion becomes autonomous. Brown tumors (BTs) are rare skeletal lesions of hyperparathyroidism that may mimic cancer metastasis. We report a case of a patient who was diagnosed with TH with multiple BTs which mimics osteolytic/osteoblastic metastases that were evaluated with two fluorodeoxyglucose positron emission tomography scans with an interval of 23 months in the preoperative and postoperative period.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
306
61
-
Feedback
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
© 2008 Indian Journal of Nuclear Medicine | Published by Wolters Kluwer -
Medknow
Online since 14
th
October, 2008